TCL Archive Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation June 29, 2012
TCL Archive Hearing Probes CDC On Cancer Treatment For Working Poor In Screening Program July 23, 1999